Hutton GJ - Search Results

1

Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update.

Pérez CA, Cuascut FX, Hutton GJ. Pérez CA, et al. Among authors: hutton gj. Neurol Clin. 2023 Feb;41(1):87-106. doi: 10.1016/j.ncl.2022.05.004. Epub 2022 Oct 31. Neurol Clin. 2023. PMID: 36400561 Review.

2

Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation.

Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R. Vu T, et al. Bone Marrow Transplant. 2007 Jun;39(11):705-9. doi: 10.1038/sj.bmt.1705666. Epub 2007 Apr 2. Bone Marrow Transplant. 2007. PMID: 17401392

3

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.

Cohen JA, Imrey PB, Calabresi PA, Edwards KR, Eickenhorst T, Felton WL 3rd, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Mandell BF, Scott TF, Zhang H, Apperson-Hansen C, Beck GJ, Houghtaling PL, Karafa MT, Stadtler M; ACT Investigators. Cohen JA, et al. Among authors: hutton gj. Neurology. 2009 Feb 10;72(6):535-41. doi: 10.1212/01.wnl.0000341934.12142.74. Neurology. 2009. PMID: 19204263 Clinical Trial.

4

A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis.

Zhang J, Hutton G, Zang Y. Zhang J, et al. Clin Ther. 2002 Dec;24(12):1998-2021. doi: 10.1016/s0149-2918(02)80094-7. Clin Ther. 2002. PMID: 12581542 Review.

5

Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.

Hong J, Zang YC, Hutton G, Rivera VM, Zhang JZ. Hong J, et al. J Neuroimmunol. 2004 Jul;152(1-2):126-39. doi: 10.1016/j.jneuroim.2004.03.004. J Neuroimmunol. 2004. PMID: 15223245

6

Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis.

Zang YC, Skinner SM, Robinson RR, Li S, Rivera VM, Hutton GJ, Zhang JZ. Zang YC, et al. Among authors: hutton gj. Mult Scler. 2004 Oct;10(5):499-506. doi: 10.1191/1352458504ms1081oa. Mult Scler. 2004. PMID: 15471364

7

Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis.

Zhang J, Hutton G. Zhang J, et al. Annu Rev Med. 2005;56:273-302. doi: 10.1146/annurev.med.56.082103.104739. Annu Rev Med. 2005. PMID: 15660513 Review.

8

Regulatory effects of interferon-β on osteopontin and interleukin-17 expression in multiple sclerosis.

Hong J, Hutton GJ. Hong J, et al. Among authors: hutton gj. J Interferon Cytokine Res. 2010 Oct;30(10):751-7. doi: 10.1089/jir.2010.0082. J Interferon Cytokine Res. 2010. PMID: 20874252 Review.

9

IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis.

Chen M, Chen G, Deng S, Liu X, Hutton GJ, Hong J. Chen M, et al. Among authors: hutton gj. J Neuroimmunol. 2012 Jan 18;242(1-2):39-46. doi: 10.1016/j.jneuroim.2011.10.014. Epub 2011 Nov 21. J Neuroimmunol. 2012. PMID: 22112394

10

Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.

Datta S, Staewen TD, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA; MRI Analysis Center at Houston; CombiRx Investigators Group. Datta S, et al. Mult Scler Relat Disord. 2015 Mar;4(2):124-36. doi: 10.1016/j.msard.2015.01.004. Epub 2015 Jan 17. Mult Scler Relat Disord. 2015. PMID: 25787188 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page